NCT01392729已完成不适用
An Open Label, Prospective, Observational, Local, Non-interventional Study of BeVacizumab (Avastin) and IntErpherone (IFN) Alpha 2a in Patients With Metastatic and Locally Advanced Renal Cell CAncer (VERA Study)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 主要终点
- Progression-free survival
研究概览
简要总结
This prospective observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in combination with interferon alpha 2a in patients with previously untreated metastatic renal cell cancer. Data will be collected from each patient for up to 4 years.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients, >/= 18 years of age
- •Histologically confirmed metastatic renal cell cancer, clear cell type
- •Eligible for treatment with Avastin and interferon alpha 2a according to local prescribing information
排除标准
- •Contraindications for Avastin or interferon alpha 2a treatment according to local Summary of Product Characteristics
- •Known hypersensitivity to Avastin and/or interferon alpha 2a or any of its excipients
结局指标
主要结局
Progression-free survival
时间窗: approximately 4 years
次要结局
- Overall survival(approximately 4 years)
- Response rate(approximately 4 years)
- Safety: Incidence of adverse events(approximately 4 years)
研究者
相似试验
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)Colorectal CancerNCT01697449Hoffmann-La Roche191
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)Colorectal CancerNCT01506167Hoffmann-La Roche719
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell CarcinomaRenal Cell CancerNCT01351571Hoffmann-La Roche5
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)Ovarian CancerNCT01863693Hoffmann-La Roche300
已完成
4 期
A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast CancerBreast CancerNCT01094184Hoffmann-La Roche49